No Data
Sector Update: Health Care Stocks Higher Late Afternoon
Health care stocks were higher late Thursday afternoon, with the NYSE Health Care Index up 0.2% and the Health Care Select Sector SPDR Fund (XLV) adding 0.3%. The iShares Biotechnology ETF (IBB) rose
Kyverna Gains as FDA Clears Trial for Lead Therapy
Kyverna Therapeutics Gets FDA Investigational New Drug Application Clearance for KYV-101 to Treat Stiff-Person Syndrome
Kyverna Therapeutics (KYTX) said Thursday the US Food and Drug Administration has cleared the company's Investigational New Drug application for KYV-101, a candidate for therapy to treat stiff-person
Kyverna Therapeutics Gets FDA IND Clearance for KYV-101
By Chris Wack Kyverna Therapeutics said it has received clearance for its Investigational New Drug, or IND, application by the U.S. Food and Drug Administration for its T-cell product candidate, KYV-
Express News | Kyverna's Kyv-101 Receives U.S. FDA Ind Clearance for Treatment of Patients With Treatment-Refractory Stiff-Person Syndrome in the Kysa-8 Phase 2 Trial
Sector Update: Health Care Stocks Decrease Late Afternoon
Health care stocks were softer late Friday afternoon, with the NYSE Health Care Index down 0.3% and the Health Care Select Sector SPDR Fund (XLV) edging down 0.1%. The iShares Biotechnology ETF (IBB)